Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): Measurement Properties and Estimated Clinically Meaningful Thresholds From a Phase 3 Study

INTRODUCTION: The NSCLC Symptom Assessment Questionnaire (NSCLC-SAQ) was developed to assess NSCLC symptom severity in accordance with Food and Drug Administration evidentiary expectations leading to Food and Drug Administration qualification in 2018. This study evaluated the NSCLC-SAQ’s measurement...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Paul, Burke, Thomas, Norquist, Josephine M., Daskalopoulou, Christina, Speck, Rebecca M., Samkari, Ayman, Eremenco, Sonya, Coons, Stephen Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983345/
https://www.ncbi.nlm.nih.gov/pubmed/35400081
http://dx.doi.org/10.1016/j.jtocrr.2022.100298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983345/
https://www.ncbi.nlm.nih.gov/pubmed/35400081
http://dx.doi.org/10.1016/j.jtocrr.2022.100298

Ejemplares similares